Literature DB >> 8571167

Lactate dehydrogenase-elevating virus: an ideal persistent virus?

P G Plagemann1, R R Rowland, C Even, K S Faaberg.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 8571167      PMCID： PMC7087530          DOI： 10.1007/bf00196164

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  71 in total

1.  Promethean viruses?

Authors:  P M Allen; R M Zinkernagel
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

2.  Subgenomic RNAs of Lelystad virus contain a conserved leader-body junction sequence.

Authors:  J J Meulenberg; E J de Meijer; R J Moormann
Journal:  J Gen Virol       Date:  1993-08       Impact factor: 3.891

Review 3.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy.

Authors:  A S Fauci
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

4.  A 29K envelope glycoprotein of equine arteritis virus expresses neutralization determinants recognized by murine monoclonal antibodies.

Authors:  U B Balasuriya; P V Rossitto; C D DeMaula; N J MacLachlan
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

5.  Pseudotype virions formed between mouse hepatitis virus and lactate dehydrogenase-elevating virus (LDV) mediate LDV replication in cells resistant to infection by LDV virions.

Authors:  C Even; P G Plagemann
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

6.  Neutralization and sensitization of lactate dehydrogenase-elevating virus with monoclonal antibodies.

Authors:  J P Coutelier; J Van Snick
Journal:  J Gen Virol       Date:  1988-08       Impact factor: 3.891

7.  Sequence of the genome of lactate dehydrogenase-elevating virus: heterogenicity between strains P and C.

Authors:  G A Palmer; L Kuo; Z Chen; K S Faaberg; P G Plagemann
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

8.  Cytotoxic T cells are elicited during acute infection of mice with lactate dehydrogenase-elevating virus but disappear during the chronic phase of infection.

Authors:  C Even; R R Rowland; P G Plagemann
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

9.  B cell diversification and differentiation in the periphery.

Authors:  G Kelsoe
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

10.  Mode of neutralization of lactate dehydrogenase-elevating virus by polyclonal and monoclonal antibodies.

Authors:  P G Plagemann; J T Harty; C Even
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574
View more
  22 in total

1.  Removal of lactate dehydrogenase-elevating virus from human-in-mouse breast tumor xenografts by cell-sorting.

Authors:  Huiping Liu; Jessica Bockhorn; Rachel Dalton; Ya-Fang Chang; Dalong Qian; Lois A Zitzow; Michael F Clarke; Geoffrey L Greene
Journal:  J Virol Methods       Date:  2011-02-24       Impact factor: 2.014

2.  Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent.

Authors:  O J Lopez; M F Oliveira; E Alvarez Garcia; B J Kwon; A Doster; F A Osorio
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

3.  Porcine reproductive and respiratory syndrome virus replicates in testicular germ cells, alters spermatogenesis, and induces germ cell death by apoptosis.

Authors:  J H Sur; A R Doster; J S Christian; J A Galeota; R W Wills; J J Zimmerman; F A Osorio
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Coexistence in lactate dehydrogenase-elevating virus pools of variants that differ in neuropathogenicity and ability to establish a persistent infection.

Authors:  Z Chen; R R Rowland; G W Anderson; G A Palmer; P G Plagemann
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Poliomyelitis in MuLV-infected ICR-SCID mice after injection of basement membrane matrix contaminated with lactate dehydrogenase-elevating virus.

Authors:  Jodi A Carlson Scholz; Rohit Garg; Susan R Compton; Heather G Allore; Caroline J Zeiss; Edward M Uchio
Journal:  Comp Med       Date:  2011-10       Impact factor: 0.982

6.  Exacerbation of autoantibody-mediated hemolytic anemia by viral infection.

Authors:  M Meite; S Léonard; M E Idrissi; S Izui; P L Masson; J P Coutelier
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  Suppression of acute anti-friend virus CD8+ T-cell responses by coinfection with lactate dehydrogenase-elevating virus.

Authors:  Shelly J Robertson; Christoph G Ammann; Ronald J Messer; Aaron B Carmody; Lara Myers; Ulf Dittmer; Savita Nair; Nicole Gerlach; Leonard H Evans; William A Cafruny; Kim J Hasenkrug
Journal:  J Virol       Date:  2007-10-24       Impact factor: 5.103

8.  B lymphocyte activation by coinfection prevents immune control of friend virus infection.

Authors:  Rute Marques; Inês Antunes; Urszula Eksmond; Jonathan Stoye; Kim Hasenkrug; George Kassiotis
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

9.  Negative impact of IFN-γ on early host immune responses to retroviral infection.

Authors:  Amanda K Duley; Mickaël J-Y Ploquin; Urszula Eksmond; Christoph G Ammann; Ronald J Messer; Lara Myers; Kim J Hasenkrug; George Kassiotis
Journal:  J Immunol       Date:  2012-07-20       Impact factor: 5.422

10.  IL-2-independent and TNF-α-dependent expansion of Vβ5+ natural regulatory T cells during retrovirus infection.

Authors:  Lara Myers; Jara J Joedicke; Aaron B Carmody; Ronald J Messer; George Kassiotis; Jaquelin P Dudley; Ulf Dittmer; Kim J Hasenkrug
Journal:  J Immunol       Date:  2013-05-03       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.